Dr. Saab on Immunotherapy in MSI-H GI Malignancies – OncLive
|
Dr. Saab on Immunotherapy in MSI-H GI Malignancies
OncLive Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses immunotherapy in a patient with microsatellite instability-high (MSI-H) gastrointestinal malignancies. Patients whose disease lacks the expression of some proteins would be … |
